[Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
Cimetidine was studied in 8 cases of Zollinger-Ellison syndrome. The average dose was 1,2 g a day for 14 to 195 days. The treatment was remarkably effective in 2 cases, but only partial or temporary improvement was noted in 3 other cases. The last 3 patients failed to respond to treatment. The possibility of a rebound phenomenon requires strict clinical and biological supervision.
D000284:Administration, Oral / Q000379:methods; D000328:Adult; D002927:Cimetidine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
D006146:Guanidines; D006635:Histamine H2 Antagonists; D002927:Cimetidine
Antagonistes des récepteurs H2 a l'histamine et traitement médical du syndrome de Zollinger-Ellison.